耐多药空洞肺结核凝胶介入疗法的远期疗效观察

Contrast observation of clinical curative effect on treatment of multi-drug resistance pulmonary tuberculosis with containing drug gelatin by bronchofiberscope

  • 摘要: 目的: 评价纤维支气管镜灌注含药凝胶治疗耐多药肺结核的临床疗效和安全性。方法: 治疗组(68例)经纤维支气管镜灌注含药凝胶治疗和用抗结核药物治疗,对照组(35例)用抗结核药物治疗。观察近期和远期疗效。结果: 治疗6月后,治疗组痰菌阴转率73. 1%,病灶治疗有效率85. 4%,空洞治疗有效率60. 5%,明显高于对照组51. 3% , 56. 7%和41. 6% (P< 0. 05), 治疗组痰菌阴转时间34. 8d,比对照组65. 2d明显缩短(P<0. 01)。随访2年后,治疗组痰菌阳转率为7. 4%,对照组为14. 3%,无显著性差异(P>0. 05)。治疗组无严重药物不良反应。结论: 纤支镜含药凝胶灌注治疗耐多药肺结核近期疗效优于单纯药物治疗,远期疗效与对照组相似。是一种治疗耐多药肺结核病有效、安全的方法。

     

    Abstract: Objective:To evaluate the clinical curative effet and safety of treatment of multi-drug resistance pulmonary tuberculosis with containing drug gelatin by fiberbronchoscoope.Methods:The 68 patients were treated with containing drug gelatin by bronchofiberscope And medication in experiment group, The 35 patients were treated only by medication in control group. the clinical curative effet in the near future and specified future date were observed.Results:At the end six month therapy, the sputum negative conversion rate was 72.1%, foci marked absorption rate was 83.3%,and cavity curative effect rate was 60.5% in experiment group, all of which were higher than that of the controls (49.6.%, 57.1% and 41.6%, P<0.05). Sputum negative conversion time was 36.3d in experiment group, it was shorter than that of the controls (61.8d, P<0.01). At the final follow up after 2 years,The sputum positive conversion rate was 7.4% in experiment group and was 14.3% in control group,There were no differences between experiment group and control group. There were not severe adverse reaction in experiment group. Conclusion:The efficiency of the containing drug gelatin by fiberbronchoscoope is better than the routine medication. experiment group was similar to control group in curative effect of specified future date. The technique was effective and safe in treatment of multi-drug resistance pulmonary tuberculosis.

     

/

返回文章
返回